Anti-PDCD1/PD-1/CD279 Antibody (Spartalizumab)
Catalog No.
F1343
Anti-PDCD1/PD-1/CD279 Antibody (Spartalizumab)
Featured Products
Spartalizumab (PDR001) is a humanized Ig4 monoclonal antibody that binds toPD-1 , and blockPD-L1 Interaction with PD-L2. Spartalizumab can be used in the study of anaplastic thyroid cancer (ATC).
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
143.14 kDa
Dry ice
1935694-88-4
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
PDR001, BAP049
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q15116
Human
Unconjugated
Monoclonal
Protein A
IgG4SP
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human PD-1 His at 2 ug/mL can bind Anti-PDCD1/PD-1/CD279 Antibody (Spartalizumab)
PDCD1 / PD-1 / CD279
Please avoid freeze-thaw cycles.